Increased Adoption of Neurostimulation Devices Stimulating Growth in the Global Neurosurgery Market

Reportstack has announced a new market research report on the Global Neurosurgery Market 2015-2019, which is expected to grow at a CAGR of 11.71 percent during the period 2014-2019.

With an increase in the launch of products, trained healthcare professionals to operate the sophisticated equipment, and collaborations among vendors, the market is expected to witness significant growth. Moreover, the increasing prevalence of neurological disorders such as epilepsy, Alzheimer's disease, and Parkinson's disease, as well as the popularity of navigation with multimodality imaging are expected to contribute significantly to the growth of the market.

“Neurostimulation devices are used in the treatment of epilepsy, migraines, post-cancer therapy pain, lower back pain, chronic pain, and Parkinson’s disease,”.

“The clinical evidence supporting the use of neurostimulation devices is increasing its adoption rate among neurosurgeons.”

Key Market Drivers

Increase in Prevalence of Neurological Disorders
Advances in Technology
Increase in Demand for MI Neurosurgeries        
Increase in Aging Population
Rise in Awareness in US

Key Market Trends

Increased Adoption of Neurostimulation Devices
Increase in Use of Frameless Stereotaxy
Growing Popularity of Awake Craniotomy

Key Market Vendors

Codman & Shurtleff Inc.
Integra LifeSciences Corp.
Medtronic Inc.
Stryker Corp.

To define the market circumstances in the next 3-4 years, the analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.

Complete report available @ Global Neurosurgery Market 2015-2019.